Subscribe to Newsletter

Small Molecules

Discovery & Development Business Practice

Design and formulation of nanomedicines

In this white paper the specific mechanisms by which nanoparticles are designed and formulated for therapeutic purposes and in which NTA has had a significant part to play is discussed.

Discovery & Development Biosimilars

Taylor Dispersion Analysis explained

Taylor Dispersion Analysis is an ultra-low volume, microcapillary flow technique for sizing and stability of biomolecules in complex solutions, and offers advantages for orthogonal and complementary biophysical characterization measurements.

Discovery & Development Business Practice

Accelerate liquid formulation development for protein biopharmaceuticals

The work presented here illustrates how Differential Scanning Calorimetry (DSC) is used in the early stages of protein characterization to rapidly provide critical data about protein stability that can be used as a guide to support and accelerate liquid formulation.

Discovery & Development Business Practice

Reverse engineering of a pharmaceutical formulation

The Morphologi G3-ID can be used to generate component-specific particle size and shape data required to aid the reverse engineering of solid oral dose formulations. Here, we provide an example case study for a powder formulation.

Manufacture Technology and Equipment

Layer by Layer

Does the fabrication of nanoparticles and nanocapules sound complex? Don’t worry – layer by layer technology allows for simple fabrication of complicated stuff.

Manufacture Small Molecules

Precision Medicine; Imprecise Manufacturing and Supply

Precision medicine holds much promise; are companies up to the challenge?

Manufacture Business Practice

Using Differential Scanning Calorimetry (DSC) to optimize antibody manufacturing

| Sponsored by Malvern Panalytical

In this white paper, we report the use of the thermal stability data obtained from DSC to screen conditions for viral inactivation of an antibody1.

Manufacture Business Practice

Binding thermodynamics of substituted diaminopyrimidine renin inhibitors

| Sponsored by Malvern Panalytical

See how thermodynamics can be used to improve your lead optimization process.

Manufacture Business Practice

Targeting protein/protein interactions in drug design

Protein interactions define a large fraction of the validated targets for drug development including cancer, diabetes, infection and autoimmune diseases.

Manufacture Standards & Regulation

A New Era of E&L Analysis

| Sponsored by Thermo Fisher Scientific

New technologies for extractables and leachables testing of small molecules and biopharmaceuticals.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

May Issue of The Medicine Maker